Pay in 4 interest-free payments of $6.76 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
AOD-9604 Adolescent (12 to 17) Dosing: What Clinicians and Parents Need to Know At a glance Regulatory status / No FDA approval for any indication or age group Typical research dose in adults / 250 to 500 mcg subcutaneous once daily (not validated in adolescents) Adolescent trial evidence / Zero published RCTs in the 12, 17 age group Key safety concern / Potential interference with growth-plate biology and pubertal GH axis Compounding status / Available only through 503A compounding pharmacies under prescriber order Primary preclinical evidence / Heffernan et al
Each batch is produced under controlled conditions to ensure sterility, consistency, and suitability for laboratory research applications
While NSAIDs generally pose minimal risks when used occasionally, they can have both minor and major implications for gut health
Limited to anecdotal evidence
TB-500 is best thought of as a tissue-repair signal and heal muscles, wounds, and soft tissues
